02/27
Headlines

Trader’s Watch List : InterMune (NASDAQ:ITMN), GrubHub (NYSE:GRUB), Uranium Resources (NASDAQ:URRE), Dynasil Corporation of America (NASDAQ:DYSL), The Hillshire Brands (NYSE:HSH)

Colin Pettis03 mins

Securities lawyers at Dunnam & Dunnam on Aug. 27 said they are investigating the board of InterMune, Inc. (NASDAQ:ITMN) in connection with a buyout for only $74 per share. Concerned ITMN investors are encouraged to contact attorney Hamilton Lindley by clicking here. “Our potential shareholder lawsuit will seek to ensure that InterMune shareholders receive the…

Read More

Whats Hot Today : GT Advanced Technologies (NASDAQ:GTAT), Mosaic (NYSE:MOS), Lucas Energy(NYSEMKT:LEI), Education Realty Trust, Inc. (NYSE:EDR), Krispy Kreme (NYSE:KKD)

Jayne Crisman03 mins

Apple has partnered with GT Advanced Technologies Inc. (NASDAQ:GTAT) last year and this has led many to contend that Apple may be planning to use the scratch resistant Sapphire stone as the screen for its touch screen. GT Advanced Technologies Inc. (NASDAQ:GTAT) belongs to Technology sector. Its weekly performance is -1.87%. On last trading day…

Read More

Worth Watching Stocks : LookSmart (NASDAQ:LOOK), Conatus Pharmaceuticals (NASDAQ:CNAT), Castlight Health (NYSE:CSLT), InterDigital (NASDAQ:IDCC), Hampden Bancorp (NASDAQ:HBNK)

Jayne Crisman03 mins

On August 14, 2014, LookSmart, Ltd. (NASDAQ:LOOK) announced that Lori House has resigned her position as the Company’s Principal Financial Officer and Principal Accounting Officer, effective August 11, 2014. She will continue to consult for the company and assist the company in preparing its financial statements and assist the accounting staff. Steven Wang, the current…

Read More

Active Watch List : Esperion Therapeutics (NASDAQ:ESPR), Office Depot (NYSE:ODP), Universal Forest NASDAQ:UFPI), First Financial Bankshares (NASDAQ:FFIN), Eldorado (NYSE:EGO)

Jason Knox03 mins

Esperion Therapeutics, Inc. (NASDAQ:ESPR) a clinical-stage biopharmaceutical company focused on developing and commercializing first-in-class, oral, low-density lipoprotein cholesterol (LDL-cholesterol) lowering therapies for the treatment of hypercholesterolemia and other cardiometabolic risk markers, on 12 Aug 2014 provided ETC-1002 development program updates and financial results for the second quarter ended June 30, 2014. In July, company initiated…

Read More

Fast Moving Stocks : Bristol-Myers Squibb Company (NYSE:BMY), InvenSense (NYSE:INVN), Tecumseh Products Company (NASDAQ:TECU), Alere (NYSE:ALR), Stryker (NYSE:SYK)

Chris Lewis03 mins

Bristol-Myers Squibb Company (NYSE:BMY) and Pfizer have announced data from a new clinical analysis showing the benefits of Eliquis in the treatment of venous thromboembolism (VTE). Bristol-Myers Squibb Company (NYSE:BMY) belongs to Healthcare sector. Its net profit margin is 16.60% and weekly performance is 0.94%. On last trading day company shares ended up $50.65. Bristol-Myers…

Read More

Tech News

Tech Analysis & Market News

Skip to content ↓